Marijuana Stock Movers For March 9, 2022

© Provided by Benzinga

GAINERS:

MGC Pharmaceuticals (OTC:MGCLF) shares closed up 19.41% at $0.02 Leviathan Natural Prods (OTC:LVCNF) shares closed up 17.02% at $0.53 Item 9 Labs (OTC:INLB) shares closed up 15.53% at $1.19 Origin Agritech (NASDAQ:SEED) shares closed up 11.52% at $9.39 Corbus Pharmaceuticals (NASDAQ:CRBP) shares closed up 7.97% at $0.37 Cara Therapeutics (NASDAQ:CARA) shares closed up 7.17% at $12.55 Village Farms Intl (NASDAQ:VFF) shares closed up 7.03% at $4.72 GreenTree Hospitality Gr (NYSE:GHG) shares closed up 6.44% at $5.62 Canopy Gwth (NASDAQ:CGC) shares closed up 6.38% at $6.67 Heritage Cannabis Holding (OTC:HERTF) shares closed up 6.00% at $0.05 Green Organic Dutchman (OTC:TGODF) shares closed up 5.86% at $0.08 EnWave (OTC:NWVCF) shares closed up 5.85% at $0.71 Charlottes Web Holdings (OTC:CWBHF) shares closed up 5.83% at $1.09 Neptune Wellness Solns (NASDAQ:NEPT) shares closed up 5.19% at $0.33 OrganiGram Holdings (NASDAQ:OGI) shares closed up 5.15% at $1.43 22nd Century Group (NASDAQ:XXII) shares closed up 4.61% at $2.27 Auxly Cannabis Group (OTC:CBWTF) shares closed up 4.35% at $0.12 Aurora Cannabis (NASDAQ:ACB) shares closed up 4.27% at $3.42 Sundial Growers (NASDAQ:SNDL) shares closed up 3.99% at $0.50 SOL Global Investments (OTC:SOLCF) shares closed up 3.99% at $1.24 HEXO (NASDAQ:HEXO) shares closed up 3.85% at $0.59 World Acceptance (NASDAQ:WRLD) shares closed up 3.85% at $179.50 Marrone Bio Innovations (NASDAQ:MBII) shares closed up 3.79% at $0.71 Tilray Brands (NASDAQ:TLRY) shares closed up 3.77% at $5.50 Alcanna (OTC:LQSIF) shares closed up 3.14% at $5.23

LOSERS:

Nine Energy Service (NYSE:NINE) shares closed down 22.44% at $4.39 Mexco Energy (AMEX:MXC) shares closed down 17.19% at $21.53 ReneSola (NYSE:SOL) shares closed down 15.66% at $6.84 Cansortium (OTC:CNTMF) shares closed down 8.38% at $0.46 MedMen Enterprises (OTC:MMNFF) shares closed down 8.15% at $0.11

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.